Director/PDMR Shareholding

RNS Number : 5199D

Feedback PLC

28 October 2020

 

Feedback plc

Director/PDMR Shareholding

London , UK, 28  October  2020   -  Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, has been informed that Rory Shaw, Non-Executive Chairman of the Company, has today purchased 5,235,446 ordinary shares in the Company ("Ordinary Shares") at an average price of 0.992 pence per Ordinary Share.

Following this purchase, Rory Shaw has a total beneficial interest in 9,818,780 Ordinary Shares, equivalent to approximately 0.92 per cent. of the Company's issued share capital.

Enquiries:

Feedback plc Tom Oakley, CEO Lindsay Melvin, CFO	[phone] [e-mail]
Allenby Capital Limited (Nominated Adviser) David Worlidge / Asha Chotai	[phone]
Peterhouse Capital Limited (Joint Broker) Lucy Williams / Duncan Vasey	[phone]
Stanford Capital Partners Limited (Joint Broker) Patrick Claridge / John Howes	[phone]
Walbrook PR Ltd	Tel: [phone] or  [e-mail]
Paul McManus/Nick Rome/Nicholas Johnson	07980 541 893 or 07748 325 236 or 07884 664 686

Notes to Editors  

Feedback plc (AIM: FDBK) is a medical imaging technology business. Its core product, Bleepa, is a revolutionary medical imaging communications app, providing an easy-to-use, high quality tool to enable remote and secure communications between front-line clinicians and teams. Importantly, it is the only CE marked medical imaging communications platform on the NHSx clinical communications tools framework. Bleepa has unparalleled functionality for everyday practice and can be accessed from any internet-connected device, enabling control of patient cases when on the go. 

Its highly scalable Software as a Service ("SaaS")-based revenue model will provide increasing levels of visibility as the Company grows its customer base. With a growing distribution base and technology in place, the focus is on leveraging key relationships in order to drive sales both in the UK and internationally to all forms of care facilitators. As a fully certified medical device, Bleepa aims to disrupt the medical imaging communications market and, importantly, increase the accuracy and speed of diagnosis.

N otification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Rory Shaw
2	Reason for the notification
a)	Position/status	Non-Executive Chairman
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Feedback plc
b)	LEI	213800UGOF2GT2U2RV90
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 0.25p each in Feedback   plc Identification code (ISIN) for Feedback plc ordinary shares: GB0003340550
b)	Nature of the transaction	Purchase of shares
c)	Price(s) and volume(s)	Price(s) Volume(s) 1.0334p 1,156,570 0.9948p 1,005,227 0.9896p 1,010,509 0.95p 1,052,631 0.9896p 1,010,509
d)	Aggregated information - Aggregated volume - Price - Principal amount	Aggregated volume: 5,235,446 Volume weighted average price: 0.992p Principal amount: £51,951.98
e)	Dates of the transaction	28 October 2020
f)	Place of transaction	London Stock Exchange

 

END

 

 

DSHPPGQUUUPUGAR